TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.80
−2.68%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−70.4x
Market Cap
$297.60M
MomentumView details →
1D Return
−2.68%
YTD Return
+155.33%
RSI (14)
56.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−70.4x
Market Cap
$297.60M
RSI (14)
56.8
MomentumView details →
1D Return
−2.68%
YTD Return
+155.33%
Similar companies
Latest newsMore news →
Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.16d agoTurn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.18d ago